Abstract
AbstractExtensive efforts are underway to develop bacteriophages as therapies against antibiotic-resistant bacteria. However, these efforts are confounded by the instability of phage preparations and a lack of suitable tools to assess active phage concentrations over time. Here, we use Dynamic Light Scattering (DLS) to measure changes in phage physical state in response to environmental factors and time, finding that phages tend to decay and form aggregates and that the degree of aggregation can be used to predict phage bioactivity. We then use DLS to optimize phage storage conditions for phages from human clinical trials, predict bioactivity in 50-year-old archival stocks, and evaluate phage samples for use in a phage therapy/wound infection model. We also provide a web-application (Phage-ELF) to facilitate DLS studies of phages. We conclude that DLS provides a rapid, convenient, and non-destructive tool for quality control of phage preparations in academic and commercial settings.Significance StatementPhages are promising for use in treating antibiotic-resistant infections, but their decay over time in refrigerated storage and higher temperatures has been a difficult barrier to overcome. This is in part because there are no suitable methods to monitor phage activity over time, especially in clinical settings. Here, we show that Dynamic Light Scattering (DLS) can be used to measure the physical state of phage preparations, which provides accurate and precise information on their lytic function – the key parameter underlying clinical efficacy. This study reveals a “structure-function” relationship for lytic phages and establishes DLS as a method to optimize the storage, handling, and clinical use of phages.
Publisher
Cold Spring Harbor Laboratory
Reference41 articles.
1. D. G. J. Larsson , C. F. Flach , Antibiotic resistance in the environment. Nat Rev Microbiol 20 (2022).
2. Geneva: World Health Organization, 2020 Antibacterial agents in clinical and preclinical development: an overview and analysis. World Health Organization 2021 (2021).
3. C. J. Murray , et al., Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet 399 (2022).
4. M. L. Ooi , et al., Safety and tolerability of bacteriophage therapy for chronic rhinosinusitis due to staphylococcus aureus. JAMA Otolaryngol Head Neck Surg 145 (2019).
5. A. Wright , C. H. Hawkins , E. E. Änggård , D. R. Harper , A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; A preliminary report of efficacy. Clinical Otolaryngology 34 (2009).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献